Preclinical data demonstrate ATYR0101's unique anti-fibrotic mechanism through interaction with LTBP-1. About ATYR0101 ATYR0101 to be showcased in oral presentation at the American Thoracic Society (ATS) 2025 Respiratory Innovation Summit. SAN DIEGO, May 14, 2025 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: ATYR) ("aTyr" or the "Company"), a clinical stage biotechnology company engaged in the discovery and development of first-in- class medicines from its proprietary tRNA synthetase platform, today announ ...

Pliant Therapeutics (PLRX) FY Conference January 10, 2023 10:30 AM ET Speaker0 All right. Good morning. Welcome back to the JPMorgan Healthcare Conference. I'm Eric Joseph, Senior Biotech Analyst with the firm. Our first presenting company this morning is Playant Therapeutics, and it's my pleasure to welcome and introduce CEO, Bernard Cooley, to talk to us a bit about the company. There'll be a Q and A after the presentation. There'll be mic circulating around the room. And for those joining online, feel fr ...